357 related articles for article (PubMed ID: 33080611)
41. Therapeutic Application of an Extract of
van Wijck Y; de Kleijn S; John-Schuster G; Mertens TCJ; Hiemstra PS; Müller A; Smits HH; Taube C
J Immunol; 2018 Mar; 200(5):1570-1579. PubMed ID: 29352004
[TBL] [Abstract][Full Text] [Related]
42. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses.
Robinson K; Kenefeck R; Pidgeon EL; Shakib S; Patel S; Polson RJ; Zaitoun AM; Atherton JC
Gut; 2008 Oct; 57(10):1375-85. PubMed ID: 18467372
[TBL] [Abstract][Full Text] [Related]
43. Host response to Helicobacter pylori infection before initiation of the adaptive immune response.
Algood HM; Gallo-Romero J; Wilson KT; Peek RM; Cover TL
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):577-86. PubMed ID: 17919297
[TBL] [Abstract][Full Text] [Related]
44. Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice.
Taylor JM; Ziman ME; Canfield DR; Vajdy M; Solnick JV
Microb Pathog; 2008 Jan; 44(1):20-7. PubMed ID: 17683897
[TBL] [Abstract][Full Text] [Related]
45. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis.
Wu YY; Tsai HF; Lin WC; Hsu PI; Shun CT; Wu MS; Hsu PN
Infect Immun; 2007 Sep; 75(9):4357-63. PubMed ID: 17562763
[TBL] [Abstract][Full Text] [Related]
46. Gastric Helicobacter pylori Infection Affects Local and Distant Microbial Populations and Host Responses.
Kienesberger S; Cox LM; Livanos A; Zhang XS; Chung J; Perez-Perez GI; Gorkiewicz G; Zechner EL; Blaser MJ
Cell Rep; 2016 Feb; 14(6):1395-1407. PubMed ID: 26854236
[TBL] [Abstract][Full Text] [Related]
47. Helicobacter pylori seropositivity protects against childhood asthma and inversely correlates to its clinical and functional severity.
Fouda EM; Kamel TB; Nabih ES; Abdelazem AA
Allergol Immunopathol (Madr); 2018; 46(1):76-81. PubMed ID: 28645881
[TBL] [Abstract][Full Text] [Related]
48. Gastric Subserous Vaccination With
Liu W; Zeng Z; Luo S; Hu C; Xu N; Huang A; Zheng L; Sundberg EJ; Xi T; Xing Y
Front Immunol; 2019; 10():1115. PubMed ID: 31156652
[TBL] [Abstract][Full Text] [Related]
49. Unraveling the mystery of the hygiene hypothesis through Helicobacter pylori infection.
Matsushima K; Nagai S
J Clin Invest; 2012 Mar; 122(3):801-4. PubMed ID: 22307323
[TBL] [Abstract][Full Text] [Related]
50. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
[TBL] [Abstract][Full Text] [Related]
51. Conventional, regulatory, and unconventional T cells in the immunologic response to Helicobacter pylori.
O'Keeffe J; Moran AP
Helicobacter; 2008 Feb; 13(1):1-19. PubMed ID: 18205661
[TBL] [Abstract][Full Text] [Related]
52. Helicobacter pylori-specific protection against inflammatory bowel disease requires the NLRP3 inflammasome and IL-18.
Engler DB; Leonardi I; Hartung ML; Kyburz A; Spath S; Becher B; Rogler G; Müller A
Inflamm Bowel Dis; 2015 Apr; 21(4):854-61. PubMed ID: 25742401
[TBL] [Abstract][Full Text] [Related]
53. Treatment with
Reuter S; Raspe J; Uebner H; Contoyannis A; Pastille E; Westendorf AM; Caso GC; Cover TL; Müller A; Taube C
Front Immunol; 2023; 14():1092801. PubMed ID: 36761723
[TBL] [Abstract][Full Text] [Related]
54. Enhanced T-helper 2 lymphocyte responses: immune mechanism of Helicobacter pylori infection.
Fan XG; Yakoob J; Fan XJ; Keeling PW
Ir J Med Sci; 1996; 165(1):37-9. PubMed ID: 8867497
[TBL] [Abstract][Full Text] [Related]
55. Interplay between Helicobacter pylori and the immune system. Clinical implications.
Szczepanik M
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():15-27. PubMed ID: 17033103
[TBL] [Abstract][Full Text] [Related]
56. Helicobacter pylori outer membrane protein 18 (Hp1125) induces dendritic cell maturation and function.
Rathinavelu S; Kao JY; Zavros Y; Merchant JL
Helicobacter; 2005 Oct; 10(5):424-32. PubMed ID: 16181353
[TBL] [Abstract][Full Text] [Related]
57. Reconsidering the "protective" hypothesis of Helicobacter pylori infection in eosinophilic esophagitis.
Doulberis M; Kountouras J; Rogler G
Ann N Y Acad Sci; 2020 Dec; 1481(1):59-71. PubMed ID: 32770542
[TBL] [Abstract][Full Text] [Related]
58. Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development.
Mitchell P; Germain C; Fiori PL; Khamri W; Foster GR; Ghosh S; Lechler RI; Bamford KB; Lombardi G
Infect Immun; 2007 Feb; 75(2):810-9. PubMed ID: 17101659
[TBL] [Abstract][Full Text] [Related]
59. Mechanisms of persistence, innate immune activation and immunomodulation by the gastric pathogen Helicobacter pylori.
Zhang X; Arnold IC; Müller A
Curr Opin Microbiol; 2020 Apr; 54():1-10. PubMed ID: 32007716
[TBL] [Abstract][Full Text] [Related]
60. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice.
Shi Y; Liu XF; Zhuang Y; Zhang JY; Liu T; Yin Z; Wu C; Mao XH; Jia KR; Wang FJ; Guo H; Flavell RA; Zhao Z; Liu KY; Xiao B; Guo Y; Zhang WJ; Zhou WY; Guo G; Zou QM
J Immunol; 2010 May; 184(9):5121-9. PubMed ID: 20351183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
